METHYLPREDNISOLONE ACEPONATE: 121 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
121
Total FAERS Reports
16 (13.2%)
Deaths Reported
48
Hospitalizations
121
As Primary/Secondary Suspect
1
Life-Threatening
9
Disabilities
First Report: 19710601 · Latest Report: 20250201
What Are the Most Common METHYLPREDNISOLONE ACEPONATE Side Effects?
#1 Most Reported
Steroid withdrawal syndrome
20 reports (16.5%)
#2 Most Reported
Skin discolouration
17 reports (14.0%)
#3 Most Reported
Pulmonary embolism
16 reports (13.2%)
All METHYLPREDNISOLONE ACEPONATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Steroid withdrawal syndrome | 20 | 16.5% | 0 | 5 |
| Skin discolouration | 17 | 14.1% | 0 | 10 |
| Erythema | 16 | 13.2% | 0 | 3 |
| Pulmonary embolism | 16 | 13.2% | 0 | 10 |
| Dyspnoea | 15 | 12.4% | 0 | 10 |
| Deep vein thrombosis | 14 | 11.6% | 0 | 10 |
| Musculoskeletal stiffness | 14 | 11.6% | 0 | 10 |
| Peripheral swelling | 14 | 11.6% | 0 | 10 |
| Coagulation test abnormal | 13 | 10.7% | 0 | 9 |
| Diarrhoea | 12 | 9.9% | 8 | 8 |
| Condition aggravated | 11 | 9.1% | 0 | 2 |
| Hypotension | 10 | 8.3% | 8 | 9 |
| Loss of personal independence in daily activities | 10 | 8.3% | 8 | 9 |
| Pelvic venous thrombosis | 10 | 8.3% | 0 | 10 |
| Pneumonia | 10 | 8.3% | 9 | 9 |
| Pruritus | 10 | 8.3% | 0 | 3 |
| Skin exfoliation | 10 | 8.3% | 0 | 2 |
| Epistaxis | 9 | 7.4% | 8 | 8 |
| Heart rate increased | 9 | 7.4% | 8 | 8 |
| Pain | 9 | 7.4% | 0 | 4 |
Who Reports METHYLPREDNISOLONE ACEPONATE Side Effects? Age & Gender Data
Gender: 68.0% female, 32.0% male. Average age: 37.7 years. Most reports from: AU. View detailed demographics →
Is METHYLPREDNISOLONE ACEPONATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 0 |
| 2011 | 1 | 0 | 0 |
| 2015 | 7 | 1 | 4 |
| 2017 | 3 | 0 | 0 |
| 2018 | 1 | 0 | 0 |
| 2019 | 18 | 3 | 11 |
| 2020 | 7 | 0 | 5 |
| 2021 | 2 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2023 | 6 | 4 | 4 |
| 2025 | 1 | 0 | 0 |
What Is METHYLPREDNISOLONE ACEPONATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 42 |
| Dermatitis atopic | 12 |
| Eczema | 10 |
| Immunosuppression | 7 |
METHYLPREDNISOLONE ACEPONATE vs Alternatives: Which Is Safer?
METHYLPREDNISOLONE ACEPONATE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE ACEPONATE vs METILDIGOXIN
METHYLPREDNISOLONE ACEPONATE vs METOCLOPRAMIDE
METHYLPREDNISOLONE ACEPONATE vs METOLAZONE
METHYLPREDNISOLONE ACEPONATE vs METOPIMAZINE
METHYLPREDNISOLONE ACEPONATE vs METOPROLOL
METHYLPREDNISOLONE ACEPONATE vs METRELEPTIN
METHYLPREDNISOLONE ACEPONATE vs METRONIDAZOLE
METHYLPREDNISOLONE ACEPONATE vs METRONIDAZOLE\METRONIDAZOLE
METHYLPREDNISOLONE ACEPONATE vs METYRAPONE
Official FDA Label for METHYLPREDNISOLONE ACEPONATE
Official prescribing information from the FDA-approved drug label.